glp 1 weight loss results emily ๐ณ dietitian | macros expert | personal trainer GLP-1 Weight Loss Injections in
Description
Pramlintide is the first FDA-approved synthetic insulin analog for the management of diabetes and can lead to a weight reduction of up to 7.9% in clinical use
This less-invasive version of the sleeve gastrectomy is performed by advanced gastroenterologists and does not require traditional surgery or cutting the skin
Its result of 28.3% over 80 weeks is meaningfully higher than standard Wegovy, higher than Wegovy HD, and higher than the current Zepbound
P = .59) (eTable 3 in Supplement 1), indicating that the role of the duration of diabetes in our study outcomes was relatively negligible
Available at: Nature
